RGPD3
gene geneOn this page
Also known as RGP3
Summary
RGPD3 (RANBP2 like and GRIP domain containing 3, HGNC:32416) is a protein-coding gene on chromosome 2q12.2, encoding RanBP2-like and GRIP domain-containing protein 3 (A6NKT7).
This gene is located in a cluster of Ran-binding protein related genes on chromosome 2 which arose through duplication in primates. The encoded protein contains an N-terminal TPR (tetratricopeptide repeat) domain, two Ran-binding domains, and a C-terminal GRIP domain (golgin-97, RanBP2alpha, Imh1p and p230/golgin-245) domain.
Source: NCBI Gene 653489 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 401 total
- Cancer driver (intOGen): loss-of-function (tumor-suppressor-like) across 3 cancer types
- MANE Select transcript:
NM_001144013
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32416 |
| Approved symbol | RGPD3 |
| Name | RANBP2 like and GRIP domain containing 3 |
| Location | 2q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | RGP3 |
| Ensembl gene | ENSG00000153165 |
| Ensembl biotype | protein_coding |
| OMIM | 612706 |
| Entrez | 653489 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000304514, ENST00000409886
RefSeq mRNA: 1 — MANE Select: NM_001144013
NM_001144013
CCDS: CCDS46379
Canonical transcript exons
ENST00000409886 — 23 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001886622 | 106403406 | 106405229 |
| ENSE00001907451 | 106468217 | 106468413 |
| ENSE00002477818 | 106459265 | 106459332 |
| ENSE00002481904 | 106436123 | 106436246 |
| ENSE00002487045 | 106433106 | 106433285 |
| ENSE00002500452 | 106436414 | 106436589 |
| ENSE00002512233 | 106452205 | 106452350 |
| ENSE00002516276 | 106435041 | 106435202 |
| ENSE00002518301 | 106432935 | 106433018 |
| ENSE00003243383 | 106434637 | 106434774 |
| ENSE00003286362 | 106434228 | 106434374 |
| ENSE00003295234 | 106438968 | 106439177 |
| ENSE00003306900 | 106452696 | 106452926 |
| ENSE00003318454 | 106441293 | 106441380 |
| ENSE00003323773 | 106413084 | 106413285 |
| ENSE00003334853 | 106456971 | 106457123 |
| ENSE00003347978 | 106436673 | 106436854 |
| ENSE00003352012 | 106425994 | 106426088 |
| ENSE00003380162 | 106429646 | 106429781 |
| ENSE00003431604 | 106423043 | 106425266 |
| ENSE00003437577 | 106447418 | 106447613 |
| ENSE00003441781 | 106457567 | 106457678 |
| ENSE00003453419 | 106415850 | 106415989 |
Expression profiles
Bgee: expression breadth ubiquitous, 125 present calls, max score 83.32.
Top tissues by expression
132 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.32 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 77.20 | silver quality |
| calcaneal tendon | UBERON:0003701 | 73.38 | gold quality |
| testis | UBERON:0000473 | 70.97 | gold quality |
| right testis | UBERON:0004534 | 70.09 | gold quality |
| left testis | UBERON:0004533 | 69.84 | gold quality |
| right lobe of liver | UBERON:0001114 | 68.76 | gold quality |
| liver | UBERON:0002107 | 64.17 | gold quality |
| ventricular zone | UBERON:0003053 | 55.87 | gold quality |
| primary visual cortex | UBERON:0002436 | 55.82 | gold quality |
| cortical plate | UBERON:0005343 | 55.53 | gold quality |
| islet of Langerhans | UBERON:0000006 | 54.69 | gold quality |
| stromal cell of endometrium | CL:0002255 | 54.12 | silver quality |
| mucosa of stomach | UBERON:0001199 | 53.85 | gold quality |
| substantia nigra | UBERON:0002038 | 51.90 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 51.71 | gold quality |
| putamen | UBERON:0001874 | 51.37 | gold quality |
| prefrontal cortex | UBERON:0000451 | 51.15 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 51.14 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 51.07 | gold quality |
| cerebral cortex | UBERON:0000956 | 51.06 | gold quality |
| ganglionic eminence | UBERON:0004023 | 50.99 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 50.98 | gold quality |
| pituitary gland | UBERON:0000007 | 50.93 | gold quality |
| frontal cortex | UBERON:0001870 | 50.81 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 50.80 | gold quality |
| pancreas | UBERON:0001264 | 50.62 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 50.35 | silver quality |
| muscle tissue | UBERON:0002385 | 50.32 | gold quality |
| hypothalamus | UBERON:0001898 | 50.24 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.72 |
| E-MTAB-6142 | no | 9.20 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
27 targeting RGPD3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-145-5P | 99.92 | 71.13 | 1836 |
| HSA-MIR-5195-3P | 99.92 | 70.92 | 1877 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
| HSA-MIR-5002-5P | 99.76 | 70.84 | 1763 |
| HSA-MIR-1296-3P | 99.72 | 64.04 | 636 |
| HSA-MIR-494-3P | 99.70 | 71.45 | 2795 |
| HSA-MIR-510-3P | 99.54 | 70.06 | 2965 |
| HSA-MIR-520A-5P | 99.35 | 66.72 | 1632 |
| HSA-MIR-525-5P | 99.35 | 66.85 | 1615 |
| HSA-MIR-6868-5P | 99.06 | 65.69 | 1284 |
| HSA-MIR-10524-5P | 99.05 | 66.08 | 963 |
| HSA-MIR-876-3P | 98.76 | 68.23 | 945 |
| HSA-MIR-603 | 98.58 | 68.28 | 1603 |
| HSA-MIR-216B-3P | 98.55 | 67.19 | 1223 |
| HSA-MIR-3613-5P | 98.40 | 68.91 | 604 |
| HSA-MIR-6773-3P | 98.17 | 65.51 | 1213 |
| HSA-MIR-1263 | 98.13 | 69.18 | 459 |
| HSA-MIR-215-3P | 97.02 | 68.01 | 1209 |
| HSA-MIR-4727-3P | 96.75 | 64.97 | 415 |
| HSA-MIR-4714-3P | 96.53 | 67.44 | 452 |
| HSA-MIR-5579-5P | 96.32 | 68.54 | 730 |
| HSA-MIR-4654 | 95.86 | 65.72 | 751 |
| HSA-MIR-10A-3P | 93.57 | 64.43 | 451 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ranbp3a | ENSDARG00000008727 |
| drosophila_melanogaster | RanBP3 | FBGN0039110 |
Paralogs (10): RGPD5 (ENSG00000015568), RANBP3 (ENSG00000031823), RANBP1 (ENSG00000099901), RANBP2 (ENSG00000153201), RANBP3L (ENSG00000164188), RGPD8 (ENSG00000169629), RGPD6 (ENSG00000183054), RGPD2 (ENSG00000185304), RGPD1 (ENSG00000187627), RGPD4 (ENSG00000196862)
Protein
Protein identifiers
RanBP2-like and GRIP domain-containing protein 3 — A6NKT7 (reviewed: A6NKT7)
All UniProt accessions (2): A6NKT7, J3KNE0
UniProt curated annotations — full annotation on UniProt →
Miscellaneous. One of the 8 copies of RANBP2 clustered close to the chromosome 2 centromere.
RefSeq proteins (1): NP_001137485* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000156 | Ran_bind_dom | Domain |
| IPR000237 | GRIP_dom | Domain |
| IPR011990 | TPR-like_helical_dom_sf | Homologous_superfamily |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR019734 | TPR_rpt | Repeat |
| IPR032023 | GCC2_Rab_bind | Domain |
| IPR045255 | RanBP1-like | Family |
Pfam: PF00638, PF01465, PF13181, PF16704
UniProt features (18 total): compositionally biased region 5, region of interest 4, domain 3, repeat 2, coiled-coil region 2, chain 1, modified residue 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NKT7-F1 | 67.49 | 0.30 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (1): 21
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 30 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, chr2q12, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_NUCLEAR_TRANSPORT, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS, GOBP_NUCLEAR_EXPORT, GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_PORE, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_SUMO_TRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOCC_ORGANELLE_ENVELOPE, GOBP_INTRACELLULAR_TRANSPORT
GO Biological Process (2): NLS-bearing protein import into nucleus (GO:0006607), intracellular transport (GO:0046907)
GO Molecular Function (2): GTPase activator activity (GO:0005096), protein binding (GO:0005515)
GO Cellular Component (2): nuclear pore (GO:0005643), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular anatomical structure | 2 |
| protein import into nucleus | 1 |
| transport | 1 |
| cellular localization | 1 |
| establishment of localization in cell | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| binding | 1 |
| nuclear envelope | 1 |
| nuclear protein-containing complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1428 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| RGPD3 | GRIP1 | Q9Y3R0 | 670 |
| RGPD3 | A0A3B3IRQ3 | A0A3B3IRQ3 | 510 |
| RGPD3 | SLC35G6 | P0C7Q6 | 434 |
| RGPD3 | KRTAP4-8 | Q9BYQ9 | 432 |
| RGPD3 | POTEM | A6NI47 | 423 |
| RGPD3 | ZNF681 | Q96N22 | 418 |
| RGPD3 | POTEC | B2RU33 | 384 |
| RGPD3 | VCF2 | Q5XKR9 | 376 |
| RGPD3 | KRTAP4-3 | Q9BYR4 | 373 |
| RGPD3 | DTD2 | Q96FN9 | 359 |
| RGPD3 | GCC2 | Q8IWJ2 | 350 |
| RGPD3 | KRTAP1-5 | Q9BYS1 | 349 |
| RGPD3 | KRTAP5-11 | Q6L8G4 | 348 |
| RGPD3 | KRTAP5-5 | Q701N2 | 348 |
| RGPD3 | ANAPC1 | Q9H1A4 | 336 |
IntAct
28 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MIA2 | RGPD3 | psi-mi:“MI:0914”(association) | 0.530 |
| AKIRIN2 | RGPD3 | psi-mi:“MI:0914”(association) | 0.530 |
| Junb | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| JUN | psi-mi:“MI:0914”(association) | 0.350 | |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| RCC1 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| ESRP1 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| CLIP1 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| RANBP1 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| XPO1 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| FGFR1OP2 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| TSNAX | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| RGPD1 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| NUP62 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| HES6 | RGPD3 | psi-mi:“MI:0914”(association) | 0.350 |
| B9D2 | RGPD3 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP152 | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP63 | CCDC66 | psi-mi:“MI:2364”(proximity) | 0.270 |
| CEP44 | CCDC85C | psi-mi:“MI:2364”(proximity) | 0.270 |
| SAMD4A | CNOT1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| DISC1 | RGPD3 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (60): RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Proximity Label-MS), RGPD3 (Proximity Label-MS), RGPD3 (Proximity Label-MS), RGPD3 (Proximity Label-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS), RGPD3 (Affinity Capture-MS)
ESM2 similar proteins: A0A0B4K7J2, A1ZAK1, A6NKT7, F4J8D3, G5ED39, H2QII6, O01510, O14715, O48767, P0DJD0, P0DJD1, P12798, P33144, P40358, P42286, P49792, Q00416, Q0IEK6, Q18508, Q18892, Q20937, Q291E4, Q2U639, Q4WVM7, Q5B8K7, Q61CW2, Q61WP7, Q6C9G0, Q6CXL5, Q6FUS3, Q6FVG5, Q70PP2, Q751J3, Q754V0, Q759B7, Q759Y1, Q75B70, Q75CM2, Q7TSH2, Q7Z3J3
Diamond homologs: A0A0B4K7J2, A6NKT7, E9Q3G8, H2QII6, O14715, P0DJD0, P0DJD1, P34022, P40517, P41920, P43487, P92985, Q09717, Q3T0M7, Q54KD9, Q7Z3J3, Q8RWG8, Q99666, Q9C829, Q9LMK7, Q9USL4, D3ZZL9, P32499, P34562, P48820, P49792, Q8CHG3, Q8IWJ2, Q9ERU9, A0A075B759, A0A075B767, A0A0B4J2A2, A0A0R0H9T5, A4FV72, D4AY02, F5H284, O00060, O49886, O93826, P0C1H7
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 27 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitotic Prometaphase | 5 | 20.4× | 3e-04 |
Disease & clinical
Cancer significance
From intOGen — cancer-driver classification: loss-of-function (tumor-suppressor-like) across 3 cancer types — HCC, LUSC, MEL.
Clinical variants and AI predictions
ClinVar
401 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 364 |
| Likely benign | 28 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3041 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:106413071:T:A | donor_gain | 1.0000 |
| 2:106413289:G:GC | acceptor_gain | 1.0000 |
| 2:106413292:T:C | acceptor_gain | 1.0000 |
| 2:106413292:T:TC | acceptor_gain | 1.0000 |
| 2:106425265:CC:C | acceptor_gain | 1.0000 |
| 2:106425266:CC:C | acceptor_gain | 1.0000 |
| 2:106425983:T:TA | donor_gain | 1.0000 |
| 2:106426089:C:CC | acceptor_gain | 1.0000 |
| 2:106428263:T:TC | acceptor_gain | 1.0000 |
| 2:106429643:CAC:C | donor_loss | 1.0000 |
| 2:106429645:CCTGT:C | donor_loss | 1.0000 |
| 2:106429778:CTTC:C | acceptor_gain | 1.0000 |
| 2:106429781:CC:C | acceptor_loss | 1.0000 |
| 2:106429781:CCTAT:C | acceptor_gain | 1.0000 |
| 2:106429782:C:CC | acceptor_gain | 1.0000 |
| 2:106429783:T:A | acceptor_loss | 1.0000 |
| 2:106429785:T:TC | acceptor_gain | 1.0000 |
| 2:106431491:TAG:T | donor_gain | 1.0000 |
| 2:106432930:CTTA:C | donor_loss | 1.0000 |
| 2:106432931:TTA:T | donor_loss | 1.0000 |
| 2:106432932:TA:T | donor_loss | 1.0000 |
| 2:106432933:A:AC | donor_gain | 1.0000 |
| 2:106432933:AC:A | donor_gain | 1.0000 |
| 2:106432934:C:CT | donor_gain | 1.0000 |
| 2:106432934:CC:C | donor_gain | 1.0000 |
| 2:106432934:CCTT:C | donor_gain | 1.0000 |
| 2:106432934:CCTTA:C | donor_gain | 1.0000 |
| 2:106433014:GAATA:G | acceptor_gain | 1.0000 |
| 2:106433015:AATA:A | acceptor_gain | 1.0000 |
| 2:106433016:ATA:A | acceptor_gain | 1.0000 |
AlphaMissense
11568 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:106424384:C:G | A1195P | 0.994 |
| 2:106436214:A:T | V556D | 0.994 |
| 2:106436454:A:G | W532R | 0.994 |
| 2:106436454:A:T | W532R | 0.994 |
| 2:106436677:A:G | L485P | 0.994 |
| 2:106436189:T:A | R564S | 0.993 |
| 2:106436189:T:G | R564S | 0.993 |
| 2:106436451:A:G | W533R | 0.993 |
| 2:106436451:A:T | W533R | 0.993 |
| 2:106436680:T:G | D484A | 0.993 |
| 2:106436681:C:G | D484H | 0.993 |
| 2:106436692:A:T | I480K | 0.993 |
| 2:106436813:A:G | W440R | 0.993 |
| 2:106436813:A:T | W440R | 0.993 |
| 2:106436146:A:G | W579R | 0.992 |
| 2:106436146:A:T | W579R | 0.992 |
| 2:106435152:A:C | S603R | 0.991 |
| 2:106435152:A:T | S603R | 0.991 |
| 2:106435154:T:G | S603R | 0.991 |
| 2:106435155:T:A | R602S | 0.991 |
| 2:106435155:T:G | R602S | 0.991 |
| 2:106436680:T:A | D484V | 0.991 |
| 2:106436680:T:C | D484G | 0.991 |
| 2:106424514:A:C | F1151L | 0.990 |
| 2:106424514:A:T | F1151L | 0.990 |
| 2:106424516:A:G | F1151L | 0.990 |
| 2:106436758:A:G | L458P | 0.990 |
| 2:106441300:G:C | S353R | 0.990 |
| 2:106441300:G:T | S353R | 0.990 |
| 2:106441302:T:G | S353R | 0.990 |
dbSNP variants (sampled 300 via entrez): RS1000067887 (2:106437530 GA>G), RS1000135126 (2:106449620 G>A), RS1000165143 (2:106404492 T>C), RS1000176027 (2:106414266 G>T), RS1000285554 (2:106413697 G>A), RS1000298913 (2:106449149 A>G), RS1000419740 (2:106470480 C>T), RS1000435597 (2:106408680 ATT>A,AT,ATTT), RS1000488209 (2:106408910 T>C), RS1000629835 (2:106412935 C>G,T), RS1000686139 (2:106469763 C>T), RS1000693554 (2:106413931 C>A,T), RS1000772207 (2:106406251 T>C), RS1000823556 (2:106469563 C>A,T), RS1000825175 (2:106406815 C>A,G,T)
Disease associations
OMIM: gene MIM:612706 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| FR900359 | affects phosphorylation | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| coumarin | affects phosphorylation | 1 |
| indeno(1,2,3-cd)pyrene | decreases expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | increases expression | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Arsenic | increases abundance, increases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Caffeine | affects phosphorylation | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Quercetin | increases phosphorylation | 1 |
| Dronabinol | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Aflatoxin M1 | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.